Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RUPAL D MATHUR

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1154683969
CMS profile
709991
Location
HOUSTON, TX

General Payments · PY2018–2024

$1,420.81

  • Reported across 55 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$481.91

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $481.91 17

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $267.25 7
VIVUS LLC $100.65 5
Lilly USA, LLC $65.37 3
Rhythm Pharmaceuticals, Inc. $27.23 1
Abbott Laboratories $21.41 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $44.92 3
PY2021 $97.85 5
PY2022 $347.60 13
PY2023 $448.53 17
PY2024 $481.91 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $21.41 08/02/2024 Food and Beverage Undisputed 01/23/2026 1124873859 CMS
Lilly USA, LLC $20.16 01/24/2024 Food and Beverage Undisputed 01/23/2026 1135378042 CMS
Lilly USA, LLC $24.84 02/07/2024 Food and Beverage Undisputed 01/23/2026 1135406568 CMS
Lilly USA, LLC $20.37 06/11/2024 Food and Beverage Undisputed 01/23/2026 1135405922 CMS
Novo Nordisk Inc $13.46 01/09/2024 Food and Beverage Undisputed 01/23/2026 1096748713 CMS
Novo Nordisk Inc $17.65 04/03/2024 Food and Beverage Undisputed 01/23/2026 1096595550 CMS
Novo Nordisk Inc $39.47 04/18/2024 Food and Beverage Undisputed 01/23/2026 1097617681 CMS
Novo Nordisk Inc $139.61 05/16/2024 Food and Beverage Undisputed 01/23/2026 1096571364 CMS
Novo Nordisk Inc $18.34 06/07/2024 Food and Beverage Undisputed 01/23/2026 1096621776 CMS
Novo Nordisk Inc $21.81 06/14/2024 Food and Beverage Undisputed 01/23/2026 1097771998 CMS
Novo Nordisk Inc $16.91 10/09/2024 Food and Beverage Undisputed 01/23/2026 1097581505 CMS
Rhythm Pharmaceuticals, Inc. $27.23 05/01/2024 Food and Beverage Undisputed 01/23/2026 1141480656 CMS
VIVUS LLC $21.47 01/04/2024 Food and Beverage Undisputed 01/23/2026 1129414786 CMS
VIVUS LLC $14.08 03/05/2024 Food and Beverage Undisputed 01/23/2026 1129414788 CMS
VIVUS LLC $20.16 03/21/2024 Food and Beverage Undisputed 01/23/2026 1129414790 CMS
VIVUS LLC $20.95 04/16/2024 Food and Beverage Undisputed 01/23/2026 1129414792 CMS
VIVUS LLC $23.99 10/22/2024 Food and Beverage Undisputed 01/23/2026 1129414794 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.